In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
In 2021, Japan launched Anamorelin, the world's first drug specifically for ···【more】
Release date:2024-08-20Recommended:232
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:183
In 2021, Ono Pharmaceutical of Japan launched Anamorelin, a ghrelin receptor ago···【more】
Release date:2024-08-20Recommended:253
Anamorelin is the first cachexia treatment drug launched in Japan in 2021, which···【more】
Release date:2024-08-20Recommended:203
Launched in Japan in 2021, anamoline is the world's first drug specifically ···【more】
Release date:2024-08-20Recommended:204
Anamorelin is the world's first drug specifically for the treatment of cache···【more】
Release date:2024-08-20Recommended:239
In 2021, Anamorelin was launched in Japan, becoming the world's first drug s···【more】
Release date:2024-08-20Recommended:173
Designed for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induc···【more】
Release date:2024-08-20Recommended:179
Mitotane was developed to address inoperable adrenal cortical carcinoma, hyperpl···【more】
Release date:2024-08-20Recommended:175
Mitotaneis specific for non-surgical adrenocortical carcinoma, hyperplasia, and ···【more】
Release date:2024-08-20Recommended:223
Mitotane is specifically developed for the treatment of inoperable adrenal corti···【more】
Release date:2024-08-20Recommended:200
Mitotane is specifically designed for the treatment of inoperable adrenal carcin···【more】
Release date:2024-08-20Recommended:221